Free Health Updates
Skip to main content
Table of Contents
< All Topics
Print

How does the CYP2D6 gene affect ADHD drug metabolism? 

Posted
Updated
ByMy Patient Advice
Author: Victoria Rowe, MSc | Reviewed by: Dr. Rebecca Fernandez, MBBS

The CYP2D6 ADHD connection is a cornerstone of pharmacogenetics, the study of how genes affect how we respond to medication. CYP2D6 is a liver enzyme responsible for metabolising a wide range of drugs, including some used to treat ADHD. Variations in this gene can significantly influence how quickly or slowly someone breaks down these medications, impacting both effectiveness and side effects. 

Take the online ADHD test

What CYP2D6 does in ADHD treatment 

CYP2D6 is a liver enzyme that plays an important role in the metabolism of several ADHD medications, especially non-stimulants. 

Metabolism and pharmacokinetics  

CYP2D6 plays a key role in the metabolism of atomoxetine (Strattera), a non-stimulant ADHD medication. People inherit different versions (or alleles) of the CYP2D6 gene, which determine how active the enzyme is. This affects the pharmacokinetics of how the drug is absorbed, distributed, metabolised, and eliminated. 

Phenotypes and drug breakdown 

Based on their CYP2D6 genotype, individuals are grouped into categories like poor, intermediate, extensive (normal), or ultrarapid metabolisers. 

Poor metabolisers break down atomoxetine slowly, leading to higher drug levels and potentially more side effects (like nausea or fatigue). 

Ultrarapid metabolisers clear the drug too quickly, which may reduce its effectiveness. 

Why it matters for ADHD care 

  • Knowing a patient’s CYP2D6 status can help guide dosing decisions, especially for atomoxetine. 
  • Clinical guidelines (like CPIC) already suggest dose adjustments based on CYP2D6 phenotype a step towards more personalised medicine in ADHD. 
  • While not standard practice yet, pharmacogenetic testing could help avoid trial-and-error prescribing and improve treatment tolerability. 

Visit providers like ADHD Certify for personal consultations that consider your genetic metabolism profile.

 For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Genetic studies and biomarkers.

Take the online ADHD test
Victoria Rowe, MSc
Author

Victoria Rowe is a health psychologist with a Master’s in Health Psychology and a BS in Applied Psychology. She has experience as a school psychologist, conducting behavioural assessments, developing individualized education plans (IEPs), and supporting children’s mental health. Dr. Rowe has contributed to peer-reviewed research on mental health, including studies on anxiety disorders and the impact of COVID-19 on healthcare systems. Skilled in SPSS, Minitab, and academic writing, she is committed to advancing psychological knowledge and promoting well-being through evidence-based practice.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Dr. Rebecca Fernandez, MBBS
Reviewer

Dr. Rebecca Fernandez is a UK-trained physician with an MBBS and experience in general surgery, cardiology, internal medicine, gynecology, intensive care, and emergency medicine. She has managed critically ill patients, stabilised acute trauma cases, and provided comprehensive inpatient and outpatient care. In psychiatry, Dr. Fernandez has worked with psychotic, mood, anxiety, and substance use disorders, applying evidence-based approaches such as CBT, ACT, and mindfulness-based therapies. Her skills span patient assessment, treatment planning, and the integration of digital health solutions to support mental well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewer's privacy. 

Categories